AJP - Regulatory, Integrative and Comparative Physiology, Vol 268, Issue 3 699-R706, Copyright © 1995 by American Physiological Society

ARTICLES

Role of corticosterone in TNF and IL-6 production in isolated perfused rat liver

J. Liao, J. A. Keiser, W. E. Scales, S. L. Kunkel and M. J. Kluger
Institute for Basic and Applied Medical Research, Lovelace Institutes, Albuquerque, New Mexico 87108.

Using an isolated perfused rat liver (IPRL) preparation, we assessed whether corticosterone may contribute to the rise in tumor necrosis factor (TNF) and interleukin-6 (IL-6) in rats after injection with lipopolysaccharide (LPS) or exposure to psychological stress. Intravenous infusion of LPS into the IPRL led to dose-dependent increases in TNF and IL-6 concentrations in the effluent. Anisomycin, a protein synthesis inhibitor, completely blocked the rise in TNF and IL-6 concentration in the IPRL effluent, supporting the hypothesis that the synthesis (or release) of these cytokines was dependent on protein synthesis. Intravenous infusion of corticosterone at nonstressed (35 ng/ml) and stressed levels (350 ng/ml) increased TNF and/or IL-6 release. However, when LPS was combined with corticosterone, the lower dose of corticosterone facilitated the release of cytokines, whereas the higher dose of corticosterone suppressed the release of cytokines. We then showed that isolated Kupffer cells were capable of significant TNF and IL-6 production and that corticosterone decreased LPS-induced cytokine production in these cells. Our data support the hypothesis that the liver is an important source of circulating cytokines in response to LPS. In addition, although in vitro data generally support the hypothesis that corticosterone suppresses the production of cytokines, our in situ data support the hypothesis that physiological levels of corticosterone cause an increase in TNF and IL-6.

This article has been cited by other articles:

				M. A. Febbraio, P. Ott, H. B. Nielsen, A. Steensberg, C. Keller, P. Krustrup, N. H. Secher, and B. K. Pedersen Hepatosplanchnic clearance of interleukin-6 in humans during exercise Am J Physiol Endocrinol Metab, August 1, 2003; 285(2): E397 - E402. [Abstract] [Full Text] [PDF]

				J. D. Johnson, K. A. O'Connor, M. K. Hansen, L. R. Watkins, and S. F. Maier Effects of prior stress on LPS-induced cytokine and sickness responses Am J Physiol Regulatory Integrative Comp Physiol, February 1, 2003; 284(2): R422 - R432. [Abstract] [Full Text] [PDF]

				J. Wang, R. Charboneau, S. Balasubramanian, R. A. Barke, H. H. Loh, and S. Roy The immunosuppressive effects of chronic morphine treatment are partially dependent on corticosterone and mediated by the {micro}-opioid receptor J. Leukoc. Biol., May 1, 2002; 71(5): 782 - 790. [Abstract] [Full Text] [PDF]

				M. G. Swain Stress and the Gastrointestinal Tract: I. Stress and hepatic inflammation Am J Physiol Gastrointest Liver Physiol, December 1, 2000; 279(6): G1135 - G1138. [Abstract] [Full Text] [PDF]

				A. F. M. W. Islam, N. D. Moss, Y. Dai, M. S. R. Smith, A. M. Collins, and G. D. F. Jackson Lipopolysaccharide-Induced Biliary Factors Enhance Invasion of Salmonella enteritidis in a Rat Model Infect. Immun., January 1, 2000; 68(1): 1 - 5. [Abstract] [Full Text] [PDF]

				T. M. Reyes and C. L. Coe Resistance of central nervous system interleukin-6 to glucocorticoid inhibition in monkeys Am J Physiol Regulatory Integrative Comp Physiol, August 1, 1998; 275(2): R612 - R618. [Abstract] [Full Text] [PDF]